全身肝素抗凝和低分子肝素抗凝是血液透析(HD)最常用的二种抗凝方法,但对于有活动性出血、高度出血危险和对肝素过敏的HD患者,这二种方法均可诱发和加重出血,严重者可导致患者死亡。临床上对这类患者常采用吸附法无肝素血液透析 Both systemic heparin anticoagulation and low molecular weight heparin anticoagulation are the two most commonly used anticoagulation methods for hemodialysis (HD), but both can be induced in HD patients with active bleeding, a high risk of bleeding, and heparin hypersensitivity And aggravating bleeding, serious cases can lead to patient death. Clinically for such patients often use adsorption without heparin hemodialysis